Verrica Pharmaceuticals Inc.VRCANASDAQ
Loading
Year-over-year free cash flow growth rate
Percentile
P9
Near historical low
vs 5Y Ago
-10.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -147.40% |
| Q3 2025 | 196.43% |
| Q2 2025 | 20.77% |
| Q1 2025 | 21.08% |
| Q4 2024 | -87.36% |
| Q3 2024 | 47.62% |
| Q2 2024 | 17.94% |
| Q1 2024 | -35.38% |
| Q4 2023 | 0.95% |
| Q3 2023 | -214.64% |
| Q2 2023 | -2.76% |
| Q1 2023 | 8.35% |
| Q4 2022 | -387.19% |
| Q3 2022 | 123.83% |
| Q2 2022 | 12.10% |
| Q1 2022 | 6.60% |
| Q4 2021 | 16.00% |
| Q3 2021 | -582.84% |
| Q2 2021 | 119.85% |
| Q1 2021 | -67.03% |
| Q4 2020 | 13.94% |
| Q3 2020 | 11.38% |
| Q2 2020 | -1.22% |
| Q1 2020 | -4.73% |
| Q4 2019 | -3.91% |
| Q3 2019 | -56.57% |
| Q2 2019 | 26.99% |
| Q1 2019 | 8.42% |
| Q4 2018 | -46.66% |
| Q3 2018 | -36.46% |
| Q2 2018 | -73.84% |
| Q1 2018 | -17.54% |
| Q4 2017 | -71.81% |
| Q3 2017 | 6.68% |
| Q2 2017 | -126.33% |
| Q1 2017 | 0.00% |